Scottish Pathology Network (SPAN) - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Scottish Pathology Network (SPAN)

Description:

Planning for Pathology in Scotland. Managed Clinical Networks. Pathology Modernisation Plan ... Confined to Histopathology/Cytopathology. North and East ... – PowerPoint PPT presentation

Number of Views:69
Avg rating:3.0/5.0
Slides: 25
Provided by: fran111
Category:

less

Transcript and Presenter's Notes

Title: Scottish Pathology Network (SPAN)


1
Scottish Pathology Network(SPAN)
  • May 2006
  • A Route for Development in Scotland?

2
Overview
  • Planning for Pathology in Scotland
  • Managed Clinical Networks
  • Pathology Modernisation Plan (England)
  • Development of Pathology Networks in Scotland
  • The Kerr Report
  • Delivering for Change
  • Where do we go from here?

3
The Past.formulation of strategy
  • No formal NHS overview above Trust/Board level
  • SMASAC
  • The Professors in Glasgow and Edinburgh
  • (Some well kent faces)

4
Scottish Pathology in a Devolved Administration
  • Recognised problems in manpower, infrastructure
  • SPAG
  • National Framework for Service Change (Kerr
    Report - Diagnostics subgroup)

5
Managed Clinical Networks
  • A Scottish concept (linked groups of health
    professionalsworking together to provide high
    quality effective services)
  • Pathology Networks central to Modernising
    Pathology Services in England
  • A means of service design across traditional
    boundaries

6
Pathology Networks in Scotland
  • Indirectly grown from SPAG
  • 2003 Network proposals through SEAT (SE and
    Tayside Planning Group) and West of Scotland
    Regional Pathology Subgroup
  • Confined to Histopathology/Cytopathology

7
North and East
  • Feb 2003 meeting of clinical and BMS heads from
    Highland, Grampian, Tayside and Fife
  • Conclusion that the idea would be beneficial and
    in keeping with HDL (2002) 69 and MEL (1999) 10
  • Subsequent meetings to draft an agreed proposal
    for funding

8
NESPAN WORKING GROUPS
  • Lymphoma (Dr J Goodlad)
  • Cytology (Dr M McKean)
  • Renal (Prof S Fleming)
  • BMS 4 (Mr B France)
  • Training (Dr P Johnston)

9
How the scheme has evolved
  • Lead clinician (FAC) chosen by Steering Group
  • Operation based on consensus
  • Meetings with SEHD (Dr Keel), Scottish Cancer
    Group, Planning Groups and West of Scotland
    representative (Dr Imrie)

10
Agreement to Proceed.
  • But
  • Networking to be made Scotland-wide
  • Funding for Manager post
  • Concerns regarding position of Edinburgh and West

11
SPAN (2005)
  • Now operational as a national MCN(MDN)
  • Membership all Departments and staff in
    Scottish Pathology
  • Internal structureto be decided at National
    Meeting

12
Who funds it?
  • Scottish Executive Health Department
  • Each Planning Group North, South/East and West
    supported by the Cancer Networks
  • Funded for 2 years in 1st Instance

13
Initially proposed working structure
14
Alternative Working Structure?
SEHD Planning Groups
Osteo
GI
Others
Skin
Head BMS
  • Scottish Pathology Network

Neuro
Paed
Breast
Gynae
Lymphoma
Cervical
  • Pathology
  • Departments

15
Context for development of Pathology in NHS
Scotland
  • Kerr and NHS reply
  • Watching developments South of the border
  • Molecular pathology (HER2, HPV)
  • Other new technologies (HPV vaccination, improved
    IT links/digital pathology)

16
If we were in Carlisle
  • Independent Review of NHS Pathology Services
  • CALL FOR EVIDENCE
  • Have you a view on the way that pathology
    services should be modernised? Do you have
    suggestions to make on the safety, quality or
    efficiency of pathology services and how they
    should be delivered in this country?
  • If so, please send your comments to the
    independent Review of Pathology Services to
    pathology.service.review_at_dh.gsi.gov.uk by the end
    of January 2006.

17
Modernising PathologyEngland Oct 05
  • ..timeliness, reliability, capacity and
    efficiency benchmarked against international
    standards.. And the feasibility..of wide scale
    reconfiguration, innovation and modernisation and
    involvement of the independent sector.

18
What Kerr saysand NHS response
  • Benchmarking (2006)
  • Managed Diagnostic Networksagreed
  • New technology - Rapid advances in automation
    mean that consideration should be given to
    rationalisation of some non acute and screening
    functions

19
Kerr.
  • Regional and National overview of service
    provisionnew developments screened across
    traditional boundaries
  • Molecular Pathologymodel of Molecular Genetics
    Consortium.agreed

20
Positives (1)
  • A rational contact point for pathology in
    Scotland (Pathology Modernisation)
  • A coherent voice at SEHD/NHS Scotland
  • Ability to influence reshaping of services
  • A formal forum for dissemination of information
    from the centre to departments (and vice versa)
  • Full time manager with a remit for facilitation
    of improvement in service delivery

21
Positives (2)
  • A flexible structure (adaptable to NHS changes)
  • Supports specialisation
  • Workforce overview
  • A Scottish school for trainee pathologists/BMS
  • Quality management support for CPA/benchmarking
  • Research/Tissue Banking
  • Scotland/Malawi partnership

22
Negatives
  • A threat to local autonomy?
  • An unnecessary layer of administration?
  • Interferes with existing structures?

23
Early examples
  • Pathalba (digital imaging/telepathology)
  • Coordinated assessment of HER-2 testing
    (molecular pathology paradigm)
  • Helping implement roll-out of colorectal cancer
    screening
  • National procurement for ICC

24
Key contacts
  • SEHD (Dr A Keel)
  • NSD (Dr A Bryson)
  • Scottish Cancer Group (Dr A Gregor, L
    Porterfield)
  • Regional Planning Groups
  • Framework Diagnostics Group (Prof G Needham)
Write a Comment
User Comments (0)
About PowerShow.com